These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15650178)

  • 41. MDA-5 is cleaved in poliovirus-infected cells.
    Barral PM; Morrison JM; Drahos J; Gupta P; Sarkar D; Fisher PB; Racaniello VR
    J Virol; 2007 Apr; 81(8):3677-84. PubMed ID: 17267501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficient cleavage of p220 by poliovirus 2Apro expression in mammalian cells: effects on vaccinia virus.
    Aldabe R; Feduchi E; Novoa I; Carrasco L
    Biochem Biophys Res Commun; 1995 Oct; 215(3):928-36. PubMed ID: 7488063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44.
    Shepley MP; Racaniello VR
    J Virol; 1994 Mar; 68(3):1301-8. PubMed ID: 7508992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The yeast Saccharomyces cerevisiae as a genetic system for obtaining variants of poliovirus protease 2A.
    Barco A; Ventoso I; Carrasco L
    J Biol Chem; 1997 May; 272(19):12683-91. PubMed ID: 9139725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2A protease is not a prerequisite for poliovirus replication.
    Igarashi H; Yoshino Y; Miyazawa M; Horie H; Ohka S; Nomoto A
    J Virol; 2010 Jun; 84(12):5947-57. PubMed ID: 20392856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibodies which block cellular receptors of poliovirus.
    Minor PD; Pipkin PA; Hockley D; Schild GC; Almond JW
    Virus Res; 1984; 1(3):203-12. PubMed ID: 6099657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication.
    Morrison ME; He YJ; Wien MW; Hogle JM; Racaniello VR
    J Virol; 1994 Apr; 68(4):2578-88. PubMed ID: 8139037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure.
    Arita M
    Microbiol Immunol; 2014 Apr; 58(4):239-56. PubMed ID: 24527995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases.
    de Breyne S; Bonderoff JM; Chumakov KM; Lloyd RE; Hellen CU
    Virology; 2008 Aug; 378(1):118-22. PubMed ID: 18572216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complexes of poliovirus serotypes with their common cellular receptor, CD155.
    He Y; Mueller S; Chipman PR; Bator CM; Peng X; Bowman VD; Mukhopadhyay S; Wimmer E; Kuhn RJ; Rossmann MG
    J Virol; 2003 Apr; 77(8):4827-35. PubMed ID: 12663789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Competing death programs in poliovirus-infected cells: commitment switch in the middle of the infectious cycle.
    Agol VI; Belov GA; Bienz K; Egger D; Kolesnikova MS; Romanova LI; Sladkova LV; Tolskaya EA
    J Virol; 2000 Jun; 74(12):5534-41. PubMed ID: 10823859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle.
    Kaplan G; Levy A; Racaniello VR
    J Virol; 1989 Jan; 63(1):43-51. PubMed ID: 2535745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An assay for the detection of interferon dependent and interferon independent antibody activities.
    Langford MP; Kaiwar R
    J Virol Methods; 1990 Nov; 30(2):151-60. PubMed ID: 2175749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic selection of poliovirus 2Apro-binding peptides.
    Ventoso I; Barco A; Carrasco L
    J Virol; 1999 Jan; 73(1):814-8. PubMed ID: 9847395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transformation of a human poliovirus receptor gene into mouse cells.
    Mendelsohn C; Johnson B; Lionetti KA; Nobis P; Wimmer E; Racaniello VR
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7845-9. PubMed ID: 3020560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Five of Five VHHs Neutralizing Poliovirus Bind the Receptor-Binding Site.
    Strauss M; Schotte L; Thys B; Filman DJ; Hogle JM
    J Virol; 2016 Jan; 90(7):3496-505. PubMed ID: 26764003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Entry of poliovirus into cells is blocked by valinomycin and concanamycin A.
    Irurzun A; Carrasco L
    Biochemistry; 2001 Mar; 40(12):3589-600. PubMed ID: 11297425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of 50- and 23-/25-kDa HeLa cell membrane glycoproteins involved in poliovirus infection: occurrence of poliovirus specific binding sites on susceptible and nonsusceptible cells.
    Barnert RH; Zeichhardt H; Habermehl KO
    Virology; 1992 Feb; 186(2):533-42. PubMed ID: 1310182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of vaccine strain mutations in domain V of the internal ribosome entry segment compared in the wild type poliovirus type 1 context.
    Malnou CE; Werner A; Borman AM; Westhof E; Kean KM
    J Biol Chem; 2004 Mar; 279(11):10261-9. PubMed ID: 14672927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analysis of dissemination pathways for poliovirus].
    Ohka S
    Uirusu; 2009 Jun; 59(1):107-14. PubMed ID: 19927995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.